Please login to the form below

Not currently logged in
Email:
Password:

Fred Powell joins Celator as chief financial officer

Joins oncology specialist from OraPharma

Fred Powell, Celator Celator has hired Fred Powell as chief financial officer.

He joins from OraPharma, and will be responsible for the oncology specialist's accounting, corporate finance, financial planning, investor relations and administration functions.

"Fred brings a tremendous skill set and experience base to a company at our stage, with a 20-year track record in the biopharmaceutical industry that includes private and public financings, mergers and acquisitions, and domestic and global operations,” said Scott Jackson, CEO of Celator Pharmaceuticals.

“He will make an immediate and substantive contribution to our success."

During his time at OraPharma, Powell helped the company through several transitions, helping to establish it as a stand-alone business after its sale by Johnson & Johnson in late 2010, and then supporting its acquisition by Valeant Pharmaceuticals in June, 2012.

Prior to joining OraPharma, he was the chief financial officer of BMP Sunstone Corporation, a US specialty pharmaceutical, overseeing its eventual sale to Sanofi.

Powell also held senior finance and administration positions at Eximias Pharmaceutical Corporation, Innaphase Corporation, and ERT (formerly EResearch Technology).

20th December 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics